United States · FDA National Drug Code directory
Matzim LA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 52544-693_fb6251e2-4e72-4fe6-9e4f-02baf57d97ca
- Product NDC
- 52544-693
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Diltiazem Hydrochloride
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110328
- Source listing expiry
- 20271231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-693-19) · 52544-693-19
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-693-30) · 52544-693-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →